GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline plc is a British multinational pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom. It is the world's third-largest pharmaceutical company measured by revenues . GSK has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions. It also has a large consumer healthcare division which produces and markets oral healthcare and nutritional products and over-the-counter medicines including Sensodyne, Boost, Horlicks and Gaviscon. GSK...
more

quick facts
NYSE symbol:GSK
Founded:2000
Headquarters:Brentford, London
Annual revenue:$42,966,000,000
Operating income:$17,659,000,000
Market cap:$140,000,000,000
Employees:103,483
Industries:Pharmaceutical industry

Products by GlaxoSmithKline

Fluticasone/salmeterol
Fluticasone/salmeterol

Revenue history for GlaxoSmithKline

RevenueDate
$42,966,000,000 December 31, 2006
« Prev  Next »

Headquarters of GlaxoSmithKline

Brentford
Brentford
Population:2,085

Brentford is a suburban town in west London, England, and part of the London Borough of Hounslow. It is located at the confluence of the River Thames and the River Brent, 8 miles west-southwest of Charing Cross. Its former ceremonial county was Middlesex. The name is recorded as Breguntford in 705...
more

Current GlaxoSmithKline board members

Sir Christopher Gent
Sir Christopher Gent
Board member since:January 2005

Sir Christopher Gent has been non-executive chairman of GlaxoSmithKline plc since January 2005. He was non-executive deputy chairman of...
more

Stephanie A. Burns
Stephanie A. Burns

Dr. Stephanie Burns is the Chairman, President and CEO of Dow Corning, a global leader in silicone based technology. Dr. Burns is a chemist that...
more

Robert A. Ingram
Robert A. Ingram
Board member since:2003

Robert A. Ingram has been a board member of Wachovia since 2001. He is the Vice Chairman- Pharmaceuticals of GlaxoSmithKline and a special consultant...
more

Roy Anderson
Roy Anderson

Sir Roy Malcolm Anderson FRS is a leading British expert on epidemiology. He has mathematically modelled the spread of diseases such as new variant...
more

Companies acquired by GlaxoSmithKline

CompanyDate:
Corixa 2005
« Prev  Next »

Venture Investments

OncoMed
OncoMed
Headquarters:Redwood City

OncoMed Pharmaceuticals is a biotechnology company dedicated to improvingcancer treatment, by developing monoclonal antibodies that target the biologicpathways critical to tumor initiating cells, also known as “cancer stemcells”. They leverage an understanding of tumor initiating cells to discoverand develop novel therapeutics that could provide important alternatives forthe treatment of cancer.

Frequently Asked Questions

  • Q:
    What companies has GlaxoSmithKline acquired?
  • A:
    Acquisitions by GlaxoSmithKline include Corixa.
  • Q:
    From which firms did GlaxoSmithKline receive investment capital?
  • A:
    GlaxoSmithKline raised venture capital from InterWest Partners.
  • Q:
    Which sectors does GlaxoSmithKline compete?
  • A:
    The company competes in Pharmaceutical company.
  • Q:
    Who are the Board Members at GlaxoSmithKline?
  • A:
    A few Board Members include:
    - Sir Christopher Gent, Chairman
    - Stephanie A. Burns, Board Member
    - Sir Christopher Gent, Deputy Chairman
    - Robert A. Ingram, Vice Chairman, Pharmaceuticals
  • Q:
    What is the stock ticker symbol and stock exchange for GlaxoSmithKline?
  • A:
    The ticker symbol is "GSK" listed on the NYSE stock exchange and "GSK" listed on the LSE stock exchange.
GlaxoSmithKline Photo Gallery

Lists

GlaxoSmithKline
Top of Page © 2012 Juggle, LLC
All Rights Reserved
Encyclopedia & Reference Resource
Some of the content on this page was provided by other sites, including
Freebase Icon (GlaxoSmithKline) or others licensed under Creative Commons